Effect of hypocalcemic protein P-MSY obtained from bovine parotid gland on the cyclic adenosine-5'-monophosphate and cyclic guanosine-5'-monophosphate contents of murine thymus and spleen cellsYAMAMOTO, H; SUZUKI, I; MIZUTANI, A et al.Chemical and pharmaceutical bulletin. 1983, Vol 31, Num 5, pp 1757-1760, issn 0009-2363Article

Correction of an in vitro immunoregulatory defect in atopic subjects by the immunostimulating drug fanetizole mesylate (CP-48,810)ROCKLIN, R. E; HEMADY, Z; MATLOFF, S et al.International journal of immunopharmacology. 1984, Vol 6, Num 1, pp 1-8, issn 0192-0561Article

Immunopharmacological characterization of a new synthetic BRM : pidotimod. WorkshopDrugs under experimental and clinical research. 1993, Vol 19, issn 0378-6501, 55 p., SUPConference Proceedings

Bacterial immunostimulant (broncho-vaxom) versus levamisole on the humoral immune response in miceBOSCH, A; LUCENA, F; PARES, R et al.Journal of immunopharmacology. 1983, Vol 5, Num 1-2, pp 107-116, issn 0163-0571Article

REPEUPLEMENT DE LA RATE PAR DES CELLULES FONCTIONNELLES CHEZ LES SOURIS IRRADIEES SOUS L'EFFET DE LA LEUCOTROPHINE ET DU POLIDINKIRICUTA I; CRIVII MS; URAY Z et al.1982; AGRESSOLOGIE; ISSN 0002-1148; FRA; DA. 1982; VOL. 23; NO 3; PP. 95-98; ABS. ENG; BIBL. 16 REF.Article

An in vitro study on the effects of isoprinosine on immune responses in cancer patientsTSANG, K. Y; FUDENBERG, H. H; PAN, J. F et al.International journal of immunopharmacology. 1983, Vol 5, Num 6, pp 481-490, issn 0192-0561Article

Muroctasin, a muramyl dipeptide derivative (an introductory overview)TSUBURA, E; AZUMA, I; UNE, T et al.Arzneimittel-Forschung. 1988, Vol 38, Num 7, pp 951-952, issn 0004-4172Article

Infection endoscopique dans le cancer de la vessieFUJITA, K.Yakuri to chiryo. 1987, Vol 15, Num 11, pp 543-546, issn 0386-3603Article

Application en thérapeutique oculaire des connaissances actuelles de l'immunologie = Application of present immunological knowledge in ophthalmologyMARTENET, A.-C.Klinische Monatsblätter für Augenheilkunde. 1985, Vol 186, Num 6, pp 428-433, issn 0023-2165Article

Immunostimulatory effect of cis-diamine dichloroplatinum(II)RIHOVA, B; DROBNIK, J; RIHA, I et al.Immunology letters. 1984, Vol 8, Num 2, pp 57-60, issn 0165-2478Article

Mechanism of enhanced humoral response in rodents by a synthetic polymerTEODORCZYK-INJEYAN, J. A; FILION, L; FALK, J et al.Journal of immunopharmacology. 1983, Vol 5, Num 3, pp 147-172, issn 0163-0571Article

Situation actuelle des immunostimulants de synthèse = Synthetic immunostimulants: present statusWERNER, G. H.Annales pharmaceutiques françaises. 1994, Vol 52, Num 2, pp 61-68, issn 0003-4509Article

Endotoxin, Tochigi-ken, Japan, May 11-13,1988FRIEDMAN, HERMAN; KLEIN, T. W; NAKANO, MASAYASU et al.Advances in experimental medicine and biology. 1990, Vol 256, issn 0065-2598Conference Proceedings

Azathioprine experience in severe, generalized, recalcitrant myasthenia gravisKORNFELD, P; AMBINDER, E. P; MATTA, R et al.The Mount Sinai journal of medicine. 1985, Vol 52, Num 5, pp 347-352, issn 0027-2507Article

The effect of BM 12.531 (azimexon) on natural killer cell activity in myeloma patients = Effet du BM 12.531 (azimexon) sur l'activité des cellules tueuses naturelles des patients atteints de myélomePETER, H. H; DZIUBA-TRABER, H; BOERNER, D et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 3, pp 353-359, issn 0277-5379Article

New commercial opportunities for liposomes emerge = Apparition de nouvelles opportunités commerciales pour les liposomesWILSON, T; CAVE, L.Bio/technology. 1983, Vol 1, Num 2, pp 148-154Article

De la physiologie à la thérapeutique : Les immunostimulants : Situations thérapeutique en... pédiatrie = Immunostimulating drugVIC, P.Est médecine. 1997, Num 52, pp 12-13, issn 0248-9643Article

Antitumor activity of cell walls from Brucella abortus = Activité antitumorale des parois cellulaires de Brucella abortusCOLLET, B; MARTIN, A; LEGARREC, Y et al.Journal of the National Cancer Institute. 1983, Vol 71, Num 3, pp 529-533, issn 0027-8874Article

Immunostimulation et infections récidivantes = Immunostimulation and recurrent infectionsMODAI, J; RENOUX, G; MARTIN, H et al.La Semaine des hôpitaux de Paris. 1983, Num 37-38, pp 2592-2593, issn 0037-1777Article

TRENDS IN IMMUNOPOTENTIATIONRENOUX G.1980; INT. J. IMMUNOPHARMACOL.; GBR; DA. 1980; VOL. 2; NO 1; PP. 1-6; BIBL. 3 P.Article

LEVAMISOLE AND AGRANULOCYTOSISKAPLAN B; CARDARELLI C; PINNELL SR et al.1979; CUTIS; USA; DA. 1979; VOL. 24; NO 4; PP. 429-430; BIBL. 22 REF.Article

International congress on biological response modifiersJournal of immunotherapy with emphasis on tumor immunology. 1995, Vol 17, Num 2, pp 114-129, issn 1067-5582Conference Proceedings

The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infectionsDREWS, J.Infection. 1984, Vol 12, Num 2, pp 157-166, issn 0300-8126Article

Effect of PSK on interferon production in tumor-bearing miceKITANI, H; TSURU, S; OGUCHI, M et al.Journal of clinical & laboratory immunology. 1984, Vol 15, Num 4, pp 211-214, issn 0141-2760Article

Immunostimulation in cancer patientsYAMAMURA, Y; AZUMA, I.Advances in experimental medicine and biology. 1983, Vol 166, pp 1-13, issn 0065-2598Article